1-20 of 90
Hongsheng Zhou
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Updated results from the Phase 1b/2 study of MK-1045, a novel CD19xCD3 T-cell engager, in adult participants with relapsed or refractory B-cell acute lymphoblastic leukemia

Free
Ying Wang, Qingsong Yin, Jinhai Ren, Hongsheng Zhou, Tiejun Gong, Feng Zhu, Xi Zhang, Qin Wen, Heng Mei, Wei Huang, Zhenghong Chen, Bhargava Kandala, Jingxia Chen, Jianxiang Wang
Journal: Blood
Blood (2025) 146 (Supplement 1): 647.
https://doi.org/10.1182/blood-2025-647
Published: 2025
Journal Articles

Novel risk stratification of ph-like ALL cohort receiving CD19-directed CAR-T therapy

Free
Cai Zihong, Bailin He, Baiwei Luo, Zhixiang Wang, Wenhao Zhong, Xuan Zhou, Qifa Liu, Peng Li, Yong-xian Hu, Jing PAN, Liang Huang, Hongsheng Zhou
Journal: Blood
Blood (2025) 146 (Supplement 1): 5108.
https://doi.org/10.1182/blood-2025-5108
Published: 2025
Journal Articles

Results of POLARIS-1, a global Phase 3 study (Part A): Olverembatinib combined with low-intensity chemotherapy in patients with newly diagnosed (ND) Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL)

Free
Suning Chen, Yu WU, Jianyu Weng, Cheng Zhang, Hongsheng Zhou, Vadim Doronin, Mei Hong, Ying Wang, Xudong Wei, Iurii Osipov, Yulia Alexeeva, Zi Chen, Yanyan Wang, Lichuang Men, Hengbang Wang, Lixin Jiang, Dengkun Xiong, Dajun Yang, Weili Zhao, Yifan Zhai
Journal: Blood
Blood (2025) 146 (Supplement 1): 1574.
https://doi.org/10.1182/blood-2025-1574
Published: 2025
Journal Articles

Kte-X19 in relapsed or refractory adult B-cell acute lymphoblastic leukemia in the Chinese population: 6-month analysis of a phase II multicenter trial

Free
Meng Lv, Hao Jiang, Yuhua Li, Yicheng Zhang, Jie Jin, Hongsheng Zhou, Kailin Xu, Mingfeng Zhao, Xin Du, Kai Hu, Jun Hu, Jinghua Zhao, Xiaojun Huang
Journal: Blood
Blood (2025) 146 (Supplement 1): 1563.
https://doi.org/10.1182/blood-2025-1563
Published: 2025
Journal Articles

Clinical study of single-center PDT-ALL-2016 regimen in the treatment of KMT2A-rearranged acute lymphoblastic leukemia

Free
Jiaxin Zheng, Bailin He, Zhixiang Wang, Xuan Zhou, Wenhao Zhong, Qifa Liu, Hongsheng Zhou
Journal: Blood
Blood (2025) 146 (Supplement 1): 6866.
https://doi.org/10.1182/blood-2025-6866
Published: 2025
Journal Articles

Real-world efficacy of inaticabtagene autoleucel in adult B-cell acute lymphoblastic leukemia patients with high-risk molecular alterations

Free
Xuan Zhou, JIN WANG, Hongsheng Zhou, Er-Lie Jiang, Chong Wang, Ying Wang, Jie Jin, Meng Lv, Xianmin Song, Xiaobing Huang, Jianmin Yang, Ruihua Mi, Lu Wang, Baohong Ping, Feng Zhu, Jing Huang, Zengjun Li, Xin Du, Jian Li, Aibin Liang, Yuhua Li
Journal: Blood
Blood (2025) 146 (Supplement 1): 6865.
https://doi.org/10.1182/blood-2025-6865
Published: 2025
Journal Articles

Efficacy and safety profile of inaticabtagene autoleucel in Chinese patients with Philadelphia chromosome-positive b-ALL: Insights from real-world data

Free
Bailin He, JIN WANG, Er-Lie Jiang, Yuhua Li, Suning Chen, Heng Mei, Ying Wang, Jianmin Yang, Jie Jin, Ji Xu, Meng Lv, Jianxiang Wang, Shengli Xue, Aibin Liang, Li Wang, Mingzhi Zhang, Xudong Wei, Zhenyang Gu, Fei Li, Chong Wang, Peng Zhao, Xin Du, Xianmin Song, Yingchang Mi, Hongsheng Zhou
Journal: Blood
Blood (2025) 146 (Supplement 1): 6855.
https://doi.org/10.1182/blood-2025-6855
Published: 2025
Journal Articles

Targeted salvage therapy improves survival in B-ALL relapsing after CD19 CAR-T: A multi-institutional study

Free
Juan Wang, Furun An, Zhouning Lin, Qianshan Tao, Hongsheng Zhou, Zhimin Zhai, Yongxian Hu
Journal: Blood
Blood (2025) 146 (Supplement 1): 6854.
https://doi.org/10.1182/blood-2025-6854
Published: 2025
Journal Articles

Efficacy and safety profile of inaticabtagene autoleucel in Chinese patients with B-cell acute lymphoblastic leukemia: Insights from real-world data

Free
JIN WANG, Hongsheng Zhou, Er-Lie Jiang, Yuhua Li, Suning Chen, Xin Du, Ji Xu, Jie Jin, Heng Mei, Xianmin Song, Jianmin Yang, Chong Wang, Aibin Liang, Guangxun Gao, Shengli Xue, Qian Jiang, Meng Lv, Xi Zhang, Xiaobing Huang, Baohong Ping, Xudong Wei, Shaowei Qiu, Liye Zhong, Feng Zhu, Hongmei Jing, Li Wang, Lu Wang, Xinsheng Xie, Pengcheng He, Zhenyang Gu, Ruihua Mi, Yang Liang, Yingchang Mi, Yu Jing, Zengjun Li, Fei Li, Mingzhi Zhang, Zhiqiang Sun, Peng Zhao, Jing Huang, Jian Li, Jianxiang Wang, Ying Wang
Journal: Blood
Blood (2025) 146 (Supplement 1): 5122.
https://doi.org/10.1182/blood-2025-5122
Published: 2025
Journal Articles

Neutrophil count is an independent prognostic indicator in early T-cell precursor lymphoblastic leukemia

Free
Jieping Lin, Xiaoyuan Gong, Nanfang Zhuo, Chengming He, Yiming Cai, Zhixiang Wang, Xuan Zhou, Bailin He, Wenhao Zhong, Qifa Liu, Suning Chen, Yang Xu, Huafeng Wang, Ying Wang, Hongsheng Zhou
Journal: Blood
Blood (2025) 146 (Supplement 1): 6892.
https://doi.org/10.1182/blood-2025-6892
Published: 2025
Journal Articles

CARMA-1: The phase I Study of SENL101, a naturally selected nanobody based CD7 CAR-T therapy, in relapsed or refractory T-ALL/lbl

Free
Xiangyu Zhao, Wei Li Zhao, Xiaoxi Zhou, Huilai Zhang, Ting Niu, Hongsheng Zhou, Aibin Liang, Xi Zhang, Meng Lv, Lingshuang Sheng, Na Kuang, Xiaojun Huang
Journal: Blood
Blood (2025) 146 (Supplement 1): 5931.
https://doi.org/10.1182/blood-2025-5931
Published: 2025
Journal Articles

Sustained Remission and Decreased Severity of CAR T-Cell Related Adverse Events: An Updated Report on the Pivotal Study of Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment in Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (r/r B-Cell ALL) in China

Free
Wang Ying, Lulu Lv, Yongping Song, Xudong Wei, Hongsheng Zhou, Qifa Liu, Kailin Xu, Dongmei Yan, Cheng Zhang, Shuangyou Liu, Jie Jin, Heng Mei, Ting Niu, Aibin Liang, Runxia Gu, Chunmei Zheng, Yi Feng, Wenqiu Huang, Shuai Xin, Wei Jin, Lin Shi, Yongzeng Wang, Jianxiang Wang
Journal: Blood
Blood (2024) 144 (Supplement 1): 4196.
https://doi.org/10.1182/blood-2024-199983
Published: 2024
Journal Articles

Evaluating the Effectiveness and Security of Antifungal Prophylaxis in Acute Lymphoblastic Leukemia Induction Chemotherapy

Free
Yang Zhou, Hongsheng Zhou, Qifa Liu
Journal: Blood
Blood (2024) 144 (Supplement 1): 4191.
https://doi.org/10.1182/blood-2024-201468
Published: 2024
Journal Articles

IKZF1 Deletion Confers Resistance to CAR19 in r/r B-ALL Via CD19 Intron Retention

Free
Cai Zihong, Baiwei Luo, Bailin He, Li Xuan, Qifa Liu, Hongsheng Zhou
Journal: Blood
Blood (2024) 144 (Supplement 1): 3412.
https://doi.org/10.1182/blood-2024-203362
Published: 2024
Journal Articles

BEAT Chemofree Regimen for Relapsed/Refractory and De Novo T-ALL

Free
Jieping Lin, Xuan Zhou, Zhixiang Wang, Dainan Lin, Yu Zhan, Zan Li, Jiwei Huang, Yonghua Li, Xudong Ma, Qifa Liu, Li Xuan, Yang Xu, Hongsheng Zhou
Journal: Blood
Blood (2024) 144 (Supplement 1): 5901.
https://doi.org/10.1182/blood-2024-203250
Published: 2024
Journal Articles

Tucidinostat Plus Pediatric-Inspired Chemotherapy As First-Line Therapy for Newly Diagnosed ETP-ALL/Lbl: An Open-Label, Single-Arm, Phase 2 Trial

Free
Jieping Lin, Chenhao Ding, Zicong Huang, Cai Zihong, Jia Li, Zhixiang Wang, Xiaofang Li, Xuan Zhou, Bailin He, Wenhao Zhong, Li Xuan, Qifa Liu, Yang Xu, Hongsheng Zhou
Journal: Blood
Blood (2024) 144 (Supplement 1): 839.
https://doi.org/10.1182/blood-2024-200513
Published: 2024
Journal Articles

Efficacy and Safety of Inaticabtagene Autoleucel in Children with Relapsed/Refractory (R/R) B-cell Acute Lymphoblastic Leukemia in China

Free
Shiyuan Wang, Xiaoming Liu, Yongjun Fang, Kailin Xu, Hongsheng Zhou, Fei Li, Xianmin Guan, Yingyi He, Yi Feng, Lulu Lyu, Qunhui Peng, Xiaofan Zhu, Jianxiang Wang
Journal: Blood
Blood (2024) 144 (Supplement 1): 7200.
https://doi.org/10.1182/blood-2024-201125
Published: 2024
Journal Articles

ABC Regimen: Combination of 3rd Generation TKI Olverembatinib, Blinatumomab and Chidamide for Older New Diagnosed Ph-Positive ALL Patients

Free
Junjie Chen, Hongsheng Zhou, Qifa Liu
Journal: Blood
Blood (2024) 144 (Supplement 1): 5881.
https://doi.org/10.1182/blood-2024-200685
Published: 2024
Journal Articles

Treatment of Acute Lymphoblastic Leukemia with PDT Regimen Improves the Prognosis of Newly Diagnosed Central Nervous System Leukemia

Free
Haimei Liang, Qifa Liu, Hongsheng Zhou
Journal: Blood
Blood (2023) 142 (Supplement 1): 5899.
https://doi.org/10.1182/blood-2023-188418
Published: 2023
Journal Articles

Frontline Combination of 3 rd Generation TKI Olverembatinib and Blinatumomab for Ph+/Ph-like ALL Patients

Free
Ting Zhang, Kaibo Zhu, Cai Zihong, Ren Lin, Qifa Liu, Hongsheng Zhou
Journal: Blood
Blood (2023) 142 (Supplement 1): 1504.
https://doi.org/10.1182/blood-2023-186139
Published: 2023